2023 was a tough year for us, but we expect a rebound in 2024: Takeda Pharmaceuticals CEO

In this video

Share

2023 was a tough year for us, but we expect a rebound in 2024: Takeda Pharmaceuticals CEO

Christophe Weber, CEO of Takeda Pharmaceuticals says product pipeline was very positive in the last quarter and shares his business outlook for 2024.
02:05
Thu, Feb 1 202410:06 PM EST